文献速递神经核医学心脏核医学

颈动脉粥样硬化炎性过程分子成像的新型靶点:一项系统综述

Novel Targets for Molecular Imaging of Inflammatory Processes of Carotid Atherosclerosis: A Systematic Review.
PubMed 文献 · Semin Nucl Med · 2023-11-23

本系统综述检索PubMed、Embase、Web of Science核心合集和Cochrane图书馆,纳入20篇关于新型分子成像示踪剂无创检测或表征颈动脉粥样硬化炎症的文章,排除仅涉及18F-FDG和18F-NaF的报告。示踪剂包括生长抑素2型受体(SST2)配体、CXC趋化因子受体4(CXCR4)配体、转位蛋白(TSPO)配体、aVβ3整合素配体和胆碱示踪剂,其摄取与心血管危险因素相关,症状性颈动脉摄取高于无症状动脉。作者谨慎提出SST2配体和胆碱放射性示踪剂可作为更大规模前瞻性纵向结局研究的可行候选。

要点

  • 新型分子成像示踪剂摄取与年龄、性别、糖尿病、高胆固醇血症、高血压及既往心血管病相关。
  • 症状性颈动脉示踪剂摄取高于无症状(包括对侧非责任)动脉。
  • 作者谨慎提出SST2配体和胆碱放射性示踪剂可作为更大规模前瞻性纵向结局研究的可行候选。

核心结论

  • 若干新型示踪剂在识别高风险斑块炎症方面显示前景。
  • 基于当前证据,作者谨慎提出SST2配体和胆碱放射性示踪剂可作为更大规模前瞻性纵向结局研究的可行候选,以评估其在临床实践中的预测用途。

研究设计与样本

  • 系统综述,检索PubMed、Embase、Web of Science核心合集和Cochrane图书馆。
  • 纳入报告分子成像无创检测或表征颈动脉粥样硬化炎症的文章,共鉴定20篇。
  • 因聚焦非经典新型靶点,排除仅涉及18F-FDG和18F-NaF的报告。

主要发现

  • 所用示踪剂为SST2配体(n=5)、CXCR4配体(n=3)、TSPO配体(n=2)、aVβ3整合素配体(n=2)和胆碱示踪剂(n=2)。
  • 示踪剂摄取与年龄、性别、糖尿病、高胆固醇血症、高血压及既往心血管病等传统心血管危险因素相关。
  • 示踪剂摄取与狭窄程度、斑块钙化及18F-FDG摄取之间存在差异。
  • 免疫组化分析将示踪剂摄取与巨噬细胞浸润和新生血管化标志物相关联。
  • 症状性颈动脉示踪剂摄取高于无症状(包括对侧非责任)动脉。

关键数值与推荐

  • 部分研究显示这些新型分子成像作为结局的特异性中间(生物)标志物具有潜在作用。

临床怎么用

  • 作者谨慎提出SST2配体和胆碱放射性示踪剂可作为更大规模前瞻性纵向结局研究的可行候选,以评估其在临床实践中的预测用途。

局限性

  • 基于当前证据,作者谨慎提出SST2配体和胆碱放射性示踪剂作为可行候选,用于更大规模前瞻性纵向结局研究以评估其预测用途。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Computed tomography angiography (CTA), magnetic resonance angiography (MRA) and 18F-FDG-PET have proven clinical value when evaluating patients with carotid atherosclerosis. In this systematic review, we will focus on the role of novel molecular imaging tracers in that assessment and their potential strengths to stratify stroke risk. We systematically searched PubMed, Embase, the Web of Science Core Collection, and Cochrane Library for articles reporting on molecular imaging to noninvasively detect or characterize inflammation in carotid atherosclerosis. As our focus was on nonclassical novel targets, we omitted reports solely on 18F-FDG and 18F-NaF. We summarized and mapped the selected studies to provide an overview of the current clinical development in molecular imaging in relation to risk factors, imaging and histological findings, diagnostic and prognostic performance. We identified 20 articles in which the utilized tracers to visualize carotid wall inflammation were somatostatin subtype-2- (SST2-) (n = 5), CXC-motif chemokine receptor 4- (CXCR4-) (n = 3), translocator protein- (TSPO-) (n = 2) and aVβ3 integrin-ligands (n = 2) and choline-tracers (n = 2). Tracer uptake correlated with traditional cardiovascular risk factors, that is, age, gender, diabetes, hypercholesterolemia, and hypertension as well as prior cardiovascular disease. We identified discrepancies between tracer uptake and grade of stenosis, plaque calcification, and 18F-FDG uptake, suggesting the importance of alternative characterization of atherosclerosis beyond classical neuroimaging features. Immunohistochemical analysis linked tracer uptake to markers of macrophage infiltration and neovascularization. Symptomatic carotid arteries showed higher uptake compared to asymptomatic (including contralateral, nonculprit) arteries. Some studies demonstrated a potential role of these novel molecular imaging as a specific intermediary (bio)marker for outcome. Several novel tracers show promise for identification of high-risk plaque inflammation. Based on the current evidence we cautiously propose the SST2-ligands and the choline radiotracers as viable candidates for larger prospective longitudinal outcome studies to evaluate their predictive use in clinical practice.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Maes L, Versweyveld L, Evans NR, et al. Novel Targets for Molecular Imaging of Inflammatory Processes of Carotid Atherosclerosis: A Systematic Review. Semin Nucl Med. 2023. PMID: 37996309. doi:10.1053/j.semnuclmed.2023.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。